22 June 2023 - Yesterday, the newly elected Presidency team of the European Federation of Pharmaceutical Industries and Associations convened in Brussels to express their concerns about the impact of the proposed Pharmaceutical Legislation - and their desire to collaborate on updating the legislation to improve the prospects of patients in Europe.

Lars Fruergaard Jørgensen, President and CEO Novo Nordisk has been elected as EFPIA President. Stefan Oelrich, Member of the Board of Management of Bayer AG and Head of its Pharmaceuticals Division, and David Loew, Chief Executive Officer of Ipsen have been elected first and second Vice Presidents.

Read EFPIA press release